(Q54614746)

English

Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21704363

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21704363

title

Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21704363

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21704363

author

Anna Simon

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21704363

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21704363

Jos W. M. van der Meer,

series ordinal

3

object named as

Jos W M van der Meer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21704363

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21704363

author name string

Heleen D de Koning

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21704363

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21704363

Joost Schalkwijk

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21704363

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21704363

language of work or name

English

0 references

publication date

25 June 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21704363

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21704363

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

The Journal of Allergy and Clinical Immunology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21704363

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21704363

volume

128

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21704363

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21704363

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21704363

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21704363

page(s)

1352-1354

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21704363

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21704363

Identifiers

DOI

10.1016/J.JACI.2011.05.023

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21704363

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21704363

PubMed publication ID

21704363

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21704363

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21704363

(Q54614746)

Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)